Heart rate reduction or ventricular reverse remodeling associated with beta-blocker therapy is accompanied widespread, distinct changes in the beta1-adrenergic receptor gene signaling network
Association of beta-blocker usage with mortality following myocardial infarction in patients with COPD: a propensity score analysis from the high-risk myocardial infarction database initiative